Cover Image
市場調查報告書

高通量篩檢 (HTS)的全球市場 - 至2021年的預測:細胞化驗、實驗室晶片、生物資訊學

High-Throughput Screening Market by Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Bioinformatics), Application (Target Identification, Primary Screening, Toxicology), Product (Reagent & Instruments), End User - Forecast to 2021

出版商 MarketsandMarkets 商品編碼 295095
出版日期 內容資訊 英文 255 Pages
訂單完成後即時交付
價格
Back to Top
高通量篩檢 (HTS)的全球市場 - 至2021年的預測:細胞化驗、實驗室晶片、生物資訊學 High-Throughput Screening Market by Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Bioinformatics), Application (Target Identification, Primary Screening, Toxicology), Product (Reagent & Instruments), End User - Forecast to 2021
出版日期: 2016年11月24日 內容資訊: 英文 255 Pages
簡介

高通量篩檢 (HTS) 市場,預計從2016年的122億3000萬美元,到2021年擴大到188億3000萬美元。預計市場2016年∼2021年以7.8%的年複合成長率成長。

本報告提供全球高通量篩檢 (HTS) 市場相關調查分析,市場概要,產業趨勢,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 高通量篩檢 (HTS) :市場概要
  • 亞太地區:高通量篩檢 (HTS) 服務市場 (各類型)
  • 高通量篩檢 (HTS) 市場:各地區概述
  • 高通量篩檢 (HTS) 市場規模:各用途
  • 高通量篩檢 (HTS) 市場:各地區結構

第5章 高通量篩檢 (HTS)的全球市場:概要

  • 簡介
  • 市場動態
    • 推動因素
    • 阻礙因素
    • 機會

第6章 高通量篩檢 (HTS)的全球市場:產業趨勢

  • 簡介
  • 波特的五力分析
  • 技術性趨勢
  • 藥物輸送流程的HTS

第7章 高通量篩檢 (HTS)的全球市場:各產品與服務

  • 簡介
  • 消耗品、試劑
  • 器具
  • 軟體、服務

第8章 高通量篩檢 (HTS)的全球市場:各技術

  • 簡介
  • 細胞化驗
  • 實驗室晶片 (Loac)
  • 超高通量篩檢 (UHTS)
  • 免標定 (無標識) 技術
  • 生物資訊學

第9章 高通量篩檢 (HTS)的全球市場:各用途

  • 標的識別
  • 一次篩檢
  • 毒性評估
  • 其他

第10章 高通量篩檢 (HTS)的全球市場:各終端用戶

  • 簡介
  • 醫藥品、生物科技企業
  • 學術、政府研究機關
  • 臨床研究委外機構 (CRO)
  • 其他

第11章 高通量篩檢 (HTS)的全球市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第12章 競爭情形

  • 簡介
  • 策略性概要
  • 市場佔有率分析
  • 競爭情形與趨勢

第13章 企業簡介

  • 簡介
  • AGILENT TECHNOLOGIES, INC.
  • DANAHER CORPORATION
  • PERKINELMER, INC.
  • THERMO FISHER SCIENTIFIC INC.
  • AXXAM S.P.A.
  • TECAN GROUP LTD.
  • BIO-RAD LABORATORIES, INC.
  • HAMILTON COMPANY
  • SIGMA-ALDRICH CORPORATION
  • AURORA BIOMED, INC.

第14章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 2220

The high-throughput screening (HTS) market is expected to grow at a lucrative CAGR of 7.8% from 2016 to 2021, to reach USD 18.83 billion by 2021 from USD 12.23 billion in 2016. Market growth can be attributed to the growing adoption of open innovative models in the pharmaceutical and biotechnology industry and technological advancements like automation and miniaturization, increasing R&D spending and rising government funding. Emerging markets and growing research activities in toxicology and stem cells provide significant growth opportunities for the market. On the other hand, the high cost and time-consuming nature of HTS techniques are restraining the growth of this market during the forecast period.

The global high-throughput screening market is segmented on the basis of product and service, technology, application end user and region. Based on product and service, the high-throughput screening market is segmented into consumables and reagents, instruments, & software and services. Based on technology, the high-throughput screening market is segmented into cell-based assays; lab-on-a-chip, ultra high-throughput screening market, label-free technology and bioinformatics. The cell-based assays segment is subsegmented into 2D cell culture, 3D cell culture and perfusion cell culture. 3D cell culture is further divided into scaffold-based technology (includes hydrogels and inert matrix/solid scaffolds segment) and scaffold-free technology (includes microplates, hanging-drop plates, ultra-low binding plates and others segment). The hydrogels scaffold-based technology is further subsegmented into animal-derived (includes matrigel and collagen segment), agarose/alginate and synthetic hydrogels. The other scaffold-free technology segment includes microfluidics, 3D bioreactors & magnetic levitation, and 3D bioprinting. Based on application, the HTS market is segmented into target identification, primary screening, toxicology assessment and others. The other application segment includes hospitals and clinical laboratories, food and agriculture industries, & environmental laboratories. Based on the end users, the market is classified into pharmaceutical and biotechnology companies, academic and government research institutes, contract research organizations (CROs) and other end users. The other end users segment includes hospitals & clinics, and food, agriculture, and environmental industries.

Geographically, North America is the largest market for high-throughput screening, followed by Europe and Asia-Pacific. However, Asia-Pacific and Latin America possess lucrative growth potential for the high-throughput screening market during the forecast period. This is mainly attributed to the increasing R&D spending; growing trend of outsourcing drug discovery services; growing public-private partnerships; and increasing government funding.

The high-throughput screening market is fragmented in nature with the presence of many small and big firms. The major players in the high-throughput screening market include Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), PerkinElmer, Inc. (U.S.) and Tecan Group Ltd. (Switzerland), Merck Millipore (U.S.), Bio-Rad laboratories (U.S.), Hamilton Company (U.S.), Axxam S.p.A. (Italy) and Aurora Biomed (Canada).

Research Coverage:

The high-throughput screening market in this report is segmented by product and service, application, technology, end user, and regions. It provides detailed information regarding major factors influencing the growth market (drivers, restraints, opportunities, and trends). The study tracks and analyzes competitive developments such as partnerships, agreements, collaborations, acquisitions, new product developments, geographical expansions, and strategically profiles the key players and comprehensively analyzes their market shares and core competencies in the high-throughput screening market

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis-industry analysis (industry trends), market share analysis of top players, and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the high-throughput screening market; high-growth regions; and market drivers, restraints, trends, and opportunities.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on portfolios offered by the top players in the global high-throughput screening market. The report analyzes the high-throughput screening market by technology, application, products and services, and end users across all the regions.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the high-throughput screening market
  • Market Development: Comprehensive information about lucrative emerging markets - the report analyzes the markets for high-throughput screening across regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global high-throughput screening market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global high-throughput screening market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED IN THE REPORT
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH APPROACH
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
    • 2.3.1. KEY DATA FROM SECONDARY SOURCES
    • 2.3.2. KEY DATA FROM PRIMARY SOURCES
    • 2.3.3. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. HIGH-THROUGHPUT SCREENING: MARKET OVERVIEW
  • 4.2. ASIA-PACIFIC: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE
  • 4.3. HIGH-THROUGHPUT SCREENING MARKET: GEOGRAPHIC SNAPSHOT
  • 4.4. HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION
  • 4.5. HIGH-THROUGHPUT SCREENING MARKET: GEOGRAPHIC MIX

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. MARKET DRIVERS
      • 5.2.1.1. Growing adoption of open innovation models in pharmaceutical and biotechnology companies
      • 5.2.1.2. Rising government funding
      • 5.2.1.3. Increasing R&D spending
      • 5.2.1.4. Technological advancements
    • 5.2.2. MARKET RESTRAINTS
      • 5.2.2.1. Capital-intensive nature of HTS
      • 5.2.2.2. Complexities in the field of assay development
    • 5.2.3. MARKET OPPORTUNITIES
      • 5.2.3.1. High growth opportunities in emerging markets
      • 5.2.3.2. Growing research activities in toxicology and stem cells

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
  • 6.2. PORTER'S FIVE FORCES ANALYSIS
    • 6.2.1. THREAT OF NEW ENTRANTS
    • 6.2.2. THREAT OF SUBSTITUTES
    • 6.2.3. BARGAINING POWER OF SUPPLIERS
    • 6.2.4. BARGAINING POWER OF BUYERS
    • 6.2.5. COMPETITIVE RIVALRY
  • 6.3. TECHNOLOGICAL TRENDS
    • 6.3.1. LABEL-FREE TECHNOLOGY, AN EMERGING TREND
    • 6.3.2. AUTOMATION & MINIATURIZATION OF HTS TECHNIQUES
  • 6.4. HTS IN DRUG DISCOVERY PROCESS

7. HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT & SERVICE

  • 7.1. INTRODUCTION
  • 7.2. CONSUMABLES & REAGENTS
  • 7.3. INSTRUMENTS
  • 7.4. SOFTWARE & SERVICES

8. HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY

  • 8.1. INTRODUCTION
  • 8.2. CELL-BASED ASSAYS
    • 8.2.1. 2D CELL CULTURE
    • 8.2.2. 3D CELL CULTURE
      • 8.2.2.1. Scaffold-based Technology
        • 8.2.2.1.1. Hydrogels
        • 8.2.2.1.1.1. Animal-derived Hydrogels
        • 8.2.2.1.1.2. Alginate/Agarose
        • 8.2.2.1.1.3. Synthetic Hydrogels
        • 8.2.2.1.2. Inert Matrix/Solid Scaffolds
      • 8.2.2.2. Scaffold-free Technology
        • 8.2.2.2.1. Microplates
        • 8.2.2.2.2. Hanging-drop Plates
        • 8.2.2.2.3. Ultra-low Binding Plates
        • 8.2.2.2.4. Other Scaffold-free Technologies
    • 8.2.3. PERFUSION CELL CULTURE
  • 8.3. LAB-ON-A-CHIP
  • 8.4. ULTRA-HIGH-THROUGHPUT SCREENING
  • 8.5. LABEL-FREE TECHNOLOGY
  • 8.6. BIOINFORMATICS

9. HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. TARGET IDENTIFICATION
  • 9.3. PRIMARY SCREENING
  • 9.4. TOXICOLOGY ASSESSMENT
  • 9.5. OTHER APPLICATIONS

10. HIGH-THROUGHPUT SCREENING MARKET, BY END USER

  • 10.1. INTRODUCTION
  • 10.2. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  • 10.3. ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES
  • 10.4. CONTRACT RESEARCH ORGANIZATIONS
  • 10.5. OTHER END USERS

11. HIGH-THROUGHPUT SCREENING MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. U.S.
    • 11.2.2. CANADA
  • 11.3. EUROPE
    • 11.3.1. GERMANY
    • 11.3.2. U.K.
    • 11.3.3. FRANCE
    • 11.3.4. ITALY
    • 11.3.5. SPAIN
    • 11.3.6. REST OF EUROPE
  • 11.4. ASIA-PACIFIC
    • 11.4.1. JAPAN
    • 11.4.2. CHINA
    • 11.4.3. INDIA
    • 11.4.4. REST OF ASIA-PACIFIC
  • 11.5. REST OF THE WORLD
    • 11.5.1. LATIN AMERICA
    • 11.5.2. MIDDLE EAST AND AFRICA

12. COMPETITIVE LANDSCAPE

  • 12.1. INTRODUCTION
  • 12.2. STRATEGIC OVERVIEW
  • 12.3. MARKET SHARE ANALYSIS
  • 12.4. COMPETITIVE SITUATION AND TRENDS
    • 12.4.1. PRODUCT LAUNCHES AND UPGRADES
    • 12.4.2. AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
    • 12.4.3. EXPANSIONS
    • 12.4.4. ACQUISITIONS
    • 12.4.5. OTHER DEVELOPMENTS

13. COMPANY PROFILES (Overview, Products and Services, Financials, Strategy & Development)*

  • 13.1. INTRODUCTION
  • 13.2. AGILENT TECHNOLOGIES, INC.
  • 13.3. DANAHER CORPORATION
  • 13.4. PERKINELMER, INC.
  • 13.5. THERMO FISHER SCIENTIFIC INC.
  • 13.6. AXXAM S.P.A.
  • 13.7. TECAN GROUP LTD.
  • 13.8. BIO-RAD LABORATORIES, INC.
  • 13.9. HAMILTON COMPANY
  • 13.10. SIGMA-ALDRICH CORPORATION (A DIVISION OF MERCK MILLIPORE)
  • 13.11. AURORA BIOMED, INC.

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

14. APPENDIX

  • 14.1. INSIGHTS OF INDUSTRY EXPERTS
  • 14.2. DISCUSSION GUIDE
  • 14.3. OTHER DEVELOPMENTS
  • 14.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.6. AVAILABLE CUSTOMIZATIONS
  • 14.7. RELATED REPORTS
  • 14.8. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: IMPACT ANALYSIS: MARKET DRIVERS
  • TABLE 2: IMPACT ANALYSIS: MARKET RESTRAINTS
  • TABLE 3: IMPACT ANALYSIS: MARKET OPPORTUNITIES
  • TABLE 4: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT, 2016-2021 (USD MILLION)
  • TABLE 5: HIGH-THROUGHPUT SCREENING CONSUMABLES & REAGENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 6: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 7: HIGH-THROUGHPUT SCREENING SOFTWARE & SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 8: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 9: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR CELL-BASED ASSAYS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 10: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR CELL-BASED ASSAYS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 11: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR 2D CELL CULTURE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 12: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR 3D CELL CULTURE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 13: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR 3D CELL CULTURE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 14: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 15: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 16: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR HYDROGELS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 17: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR HYDROGELS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 18: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 19: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 20: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR MATRIGEL, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 21: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR COLLAGEN, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 22: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR ALGINATE/AGAROSE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 23: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 24: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR INERT MATRIX/SOLID SCAFFOLDS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 25: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 26: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 27: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR MICROPLATES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 28: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR HANGING-DROP PLATES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 29: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR ULTRA-LOW BINDING PLATES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 30: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 31: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR PERFUSION CELL CULTURE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 32: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR LAB-ON-A-CHIP, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 33: ULTRA-HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 34: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 35: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR BIOINFORMATICS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 36: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 37: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR TARGET IDENTIFICATION, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 38: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR PRIMARY SCREENING, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 39: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR TOXICOLOGY ASSESSMENT, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 40: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 41: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 42: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 43: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 44: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 45: HIGH-THROUGHPUT SCREENING MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 46: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 47: NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 48: NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 49: NORTH AMERICA: CELL-BASED ASSAYS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 50: NORTH AMERICA: 3D CELL CULTURE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 51: NORTH AMERICA: SCAFFOLD-BASED TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 52: NORTH AMERICA: HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 53: NORTH AMERICA: ANIMAL-DERIVED HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 54: NORTH AMERICA: SCAFFOLD-FREE TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 55: NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 56: NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 57: NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 58: U.S.: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 59: U.S.: CELL-BASED ASSAYS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 60: U.S.: 3D CELL CULTURE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 61: U.S.: SCAFFOLD-BASED TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 62: U.S.: HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 63: U.S.: ANIMAL-DERIVED HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 64: U.S.: SCAFFOLD-FREE TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 65: U.S.: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 66: U.S.: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 67: U.S.: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 68: CANADA: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 69: CANADA: CELL-BASED ASSAYS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 70: CANADA: 3D CELL CULTURE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 71: CANADA: SCAFFOLD-BASED TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 72: CANADA: HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 73: CANADA: ANIMAL-DERIVED HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 74: CANADA: SCAFFOLD-FREE TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 75: CANADA: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 76: CANADA: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 77: CANADA: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 78: PHARMACEUTICAL INDUSTRY R&D EXPENDITURE IN EUROPE, BY COUNTRY, 2014 (USD MILLION)
  • TABLE 79: EUROPE: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 80: EUROPE: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 81: EUROPE: CELL-BASED ASSAYS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 82: EUROPE: 3D CELL CULTURE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 83: EUROPE: SCAFFOLD-BASED TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 84: EUROPE: HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 85: EUROPE: ANIMAL-DERIVED HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 86: EUROPE: SCAFFOLD-FREE TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 87: EUROPE: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 88: EUROPE: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 89: EUROPE: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 90: GERMANY: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 91: GERMANY: CELL-BASED ASSAYS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 92: GERMANY: 3D CELL CULTURE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 93: GERMANY: SCAFFOLD-BASED TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 94: GERMANY: HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 95: GERMANY: ANIMAL-DERIVED HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 96: GERMANY: SCAFFOLD-FREE TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 97: GERMANY: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 98: GERMANY: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 99: GERMANY: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 100: U.K.: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 101: U.K.: CELL-BASED ASSAYS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 102: U.K.: 3D CELL CULTURE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 103: U.K.: SCAFFOLD-BASED TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 104: U.K.: HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 105: U.K.: ANIMAL-DERIVED HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 106: U.K.: SCAFFOLD-FREE TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 107: U.K.: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 108: U.K.: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 109: U.K.: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 110: FRANCE: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 111: FRANCE: CELL-BASED ASSAYS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 112: FRANCE: 3D CELL CULTURE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 113: FRANCE: SCAFFOLD-BASED TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 114: FRANCE: HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 115: FRANCE: ANIMAL-DERIVED HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 116: FRANCE: SCAFFOLD-FREE TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 117: FRANCE: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 118: FRANCE: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 119: FRANCE: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 120: ITALY: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 121: ITALY: CELL-BASED ASSAYS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 122: ITALY: 3D CELL CULTURE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 123: ITALY: SCAFFOLD-BASED TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 124: ITALY: HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 125: ITALY: ANIMAL-DERIVED HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 126: ITALY: SCAFFOLD-FREE TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 127: ITALY: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 128: ITALY: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 129: ITALY: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 130: SPAIN: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 131: SPAIN: CELL-BASED ASSAYS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 132: SPAIN: 3D CELL CULTURE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 133: SPAIN: SCAFFOLD-BASED TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 134: SPAIN: HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 135: SPAIN: ANIMAL-DERIVED HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 136: SPAIN: SCAFFOLD-FREE TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 137: SPAIN: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 138: SPAIN: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 139: SPAIN: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 140: ROE: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 141: ROE: CELL-BASED ASSAYS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 142: ROE: 3D CELL CULTURE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 143: ROE: SCAFFOLD-BASED TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 144: ROE: HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 145: ROE: ANIMAL-DERIVED HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 146: ROE: SCAFFOLD-FREE TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 147: ROE: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 148: ROE: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 149: ROE: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 150: APAC: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 151: APAC: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 152: APAC: CELL-BASED ASSAYS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 153: APAC: 3D CELL CULTURE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 154: APAC: SCAFFOLD-BASED TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 155: APAC: HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 156: APAC: ANIMAL-DERIVED HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 157: APAC: SCAFFOLD-FREE TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 158: APAC: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 159: APAC: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 160: APAC: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 161: JAPAN: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 162: JAPAN: CELL-BASED ASSAYS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 163: JAPAN: 3D CELL CULTURE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 164: JAPAN: SCAFFOLD-BASED TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 165: JAPAN: HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 166: JAPAN: ANIMAL-DERIVED HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 167: JAPAN: SCAFFOLD-FREE TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 168: JAPAN: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 169: JAPAN: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 170: JAPAN: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 171: CHINA: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 172: CHINA: CELL-BASED ASSAYS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 173: CHINA: 3D CELL CULTURE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 174: CHINA: SCAFFOLD-BASED TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 175: CHINA: HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 176: CHINA: ANIMAL-DERIVED HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 177: CHINA: SCAFFOLD-FREE TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 178: CHINA: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 179: CHINA: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 180: CHINA: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 181: INDIA: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 182: INDIA: CELL-BASED ASSAYS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 183: INDIA: 3D CELL CULTURE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 184: INDIA: SCAFFOLD-BASED TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 185: INDIA: HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 186: INDIA: ANIMAL-DERIVED HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 187: INDIA: SCAFFOLD-FREE TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 188: INDIA: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 189: INDIA: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 190: INDIA: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 191: ROAPAC: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 192: ROAPAC: CELL-BASED ASSAYS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 193: ROAPAC: 3D CELL CULTURE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 194: ROAPAC: SCAFFOLD-BASED TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 195: ROAPAC: HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 196: ROAPAC: ANIMAL-DERIVED HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 197: ROAPAC: SCAFFOLD-FREE TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 198: ROAPAC: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 199: ROAPAC: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 200: ROAPAC: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 201: ROW: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 202: ROW: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 203: ROW: CELL-BASED ASSAYS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 204: ROW: 3D CELL CULTURE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 205: ROW: SCAFFOLD-BASED TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 206: ROW: HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 207: ROW: ANIMAL-DERIVED HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 208: ROW: SCAFFOLD-FREE TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 209: ROW: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 210: ROW: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 211: ROW: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 212: LATIN AMERICA: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 213: LATIN AMERICA: CELL-BASED ASSAYS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 214: LATIN AMERICA: 3D CELL CULTURE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 215: LATIN AMERICA: SCAFFOLD-BASED TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 216: LATIN AMERICA: HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 217: LATIN AMERICA: ANIMAL-DERIVED HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 218: LATIN AMERICA: SCAFFOLD-FREE TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 219: LATIN AMERICA: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 220: LATIN AMERICA: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 221: LATIN AMERICA: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 222: MIDDLE EAST AND AFRICA: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 223: MIDDLE EAST AND AFRICA: CELL-BASED ASSAYS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 224: MIDDLE EAST AND AFRICA: 3D CELL CULTURE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 225: MIDDLE EAST AND AFRICA: SCAFFOLD-BASED TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 226: MIDDLE EAST AND AFRICA: HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 227: MIDDLE EAST AND AFRICA: ANIMAL-DERIVED HYDROGELS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 228: MIDDLE EAST AND AFRICA: SCAFFOLD-FREE TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 229: MIDDLE EAST AND AFRICA: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 230: MIDDLE EAST AND AFRICA: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 231: MIDDLE EAST AND AFRICA: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 232: MARKET DEVELOPMENTS, BY COMPANY, 2013-2016
  • TABLE 233: PRODUCT LAUNCHES AND UPGRADES, 2013-2016
  • TABLE 234: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2013-2016
  • TABLE 235: EXPANSIONS, 2013-2016
  • TABLE 236: ACQUISITIONS, 2013-2016
  • TABLE 237: OTHER DEVELOPMENTS, 2013-2016

LIST OF FIGURES

  • FIGURE 1: HIGH-THROUGHPUT SCREENING MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: GLOBAL HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCTS AND SERVICES, 2016 VS. 2021 (USD MILLION)
  • FIGURE 8: GLOBAL HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2016 VS. 2021 (USD MILLION)
  • FIGURE 9: GLOBAL HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY, 2016 VS. 2021 (USD MILLION)
  • FIGURE 10: GLOBAL HIGH-THROUGHPUT SCREENING MARKET, BY END USER, 2016 VS. 2021 (USD MILLION)
  • FIGURE 11: GEOGRAPHIC SNAPSHOT: HIGH-THROUGHPUT SCREENING MARKET
  • FIGURE 12: ADOPTION OF OPEN INNOVATIVE MODELS BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IS PROPELLING GROWTH IN THE HIGH-THROUGHPUT SCREENING MARKET
  • FIGURE 13: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES COMMANDED THE LARGEST SHARE OF THE ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET IN 2015
  • FIGURE 14: THE U.S. ACCOUNTED FOR THE LARGEST SHARE OF THE HIGH-THROUGHPUT SCREENING TECHNOLOGIES MARKET IN 2015
  • FIGURE 15: THE TARGET IDENTIFICATION SEGMENT WILL CONTINUE TO DOMINATE THE HIGH-THROUGHPUT SCREENING MARKET IN 2021
  • FIGURE 16: NORTH AMERICA TO WITNESS THE HIGHEST GROWTH RATE IN THE HIGH-THROUGHPUT SCREENING MARKET DURING THE FORECAST PERIOD
  • FIGURE 17: HIGH-THROUGHPUT SCREENING MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
  • FIGURE 18: PHARMACEUTICAL R&D EXPENDITURE, BY GEOGRAPHY, 2000 VS. 2010 VS. 2014
  • FIGURE 19: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 20: DRUG DISCOVERY PROCESS
  • FIGURE 21: HIGH-THROUGHPUT SCREENING MARKET SEGMENTATION, BY PRODUCT
  • FIGURE 22: HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY, 2016 VS. 2021 (USD MILLION)
  • FIGURE 23: HIGH-THROUGHPUT SCREENING MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 24: HIGH-THROUGHPUT SCREENING MARKET FOR 3D CELL CULTURE, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 25: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2016
  • FIGURE 26: HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2016-2021 (USD MILLION)
  • FIGURE 27: HIGH-THROUGHPUT SCREENING MARKET: GEOGRAPHIC SNAPSHOT (2016)
  • FIGURE 28: NORTH AMERICA: HTS MARKET SNAPSHOT
  • FIGURE 29: ASIA-PACIFIC: HTS MARKET SNAPSHOT
  • FIGURE 30: KEY DEVELOPMENTS IN THE HIGH-THROUGHPUT SCREENING MARKET, 2013-2016
  • FIGURE 31: GLOBAL HIGH-THROUGHPUT SCREENING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
  • FIGURE 32: FINANCIAL PERFORMANCES OF THE LEADING MARKET PLAYERS
  • FIGURE 33: AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • FIGURE 34: DANAHER CORPORATION: COMPANY SNAPSHOT
  • FIGURE 35: PERKINELMER, INC.: COMPANY SNAPSHOT
  • FIGURE 36: THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
  • FIGURE 37: TECAN GROUP LTD.: COMPANY SNAPSHOT
  • FIGURE 38: BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
  • FIGURE 39: MERCK MILLIPORE: COMPANY SNAPSHOT
Back to Top